How an EBV Vaccine Could Be a Major MS Disrupter

WHY IT MATTERS

If successful, an EBV vaccine could prevent MS from developing in the first place, offering a potential cure-like approach rather than just managing symptoms after diagnosis.

Scientists are testing a new vaccine against Epstein-Barr virus (EBV), a common virus that may trigger multiple sclerosis (MS). Early research suggests that preventing EBV infection could help prevent or reduce MS development. This vaccine could be a major breakthrough for people at risk of developing MS or those already living with the disease.

New trials focused on an Epstein-Barr virus vaccine could bring hope to people living with multiple sclerosis (MS). The post How an EBV Vaccine Could Be a Major MS Disrupter appeared first on Rare Disease Advisor

Related conditions